Retatrutide
Price range: $60.00 through $380.00
Retatrutide — available in multiple dosages. For research use only.
Retatrutide Peptide: Triple Agonist for Metabolic Research
Retatrutide is a synthetic 39-amino-acid peptide engineered as a triple receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. Unlike single-pathway compounds, this molecule allows researchers to study coordinated incretin and glucagon signaling in models of metabolic dysregulation, energy balance, and substrate utilization.
If you are searching for how to get retatrutide , you have likely discovered what most researchers already know: this compound is scarce. Supply chain disruptions, customs seizures of international shipments, and limited domestic synthesis capacity have made Retatrutide one of the most difficult research peptides to source in 2026. Pure Peptide Factory has secured dedicated batch production. We stock Retatrutide in our domestic cold-storage facility and ship same-day to research institutions nationwide.
Why Pure Peptide Factory Is the Best Place to Buy Retatrutide Online
Domestic Inventory When Competitors Are Out of Stock
Most peptide vendors do not carry Retatrutide. The ones that do often ship from overseas with 3 to 6 week delivery times and no customs guarantee. We synthesize and store Retatrutide domestically. When you order, your compound ships from our facility to your lab in 1 to 3 business days inside temperature-controlled packaging with phase-change cooling.
Triple Agonist Expertise
Retatrutide is not a beginner compound. Its three-receptor mechanism requires precise handling and storage protocols. Our technical team includes metabolic researchers who understand GIP, GLP-1, and glucagon pathway interactions. When you buy from us, you get protocol guidance, concentration calculators, and storage recommendations specific to triple-agonist research.
Batch Documentation for Multi-Site Studies
Retatrutide research often spans multiple institutions. Every vial ships with a lot-specific COA, HPLC chromatogram, and mass spectrometry report. We archive synthesis logs for 24 months so you can maintain consistency across study sites and satisfy institutional review board requirements.
What Is Retatrutide?
The Triple Agonist Mechanism
Retatrutide (LY3437943) activates three distinct receptors with a single peptide structure:
-
GIP receptor: Potent activation, stronger than GLP-1 or glucagon in some assay systems
-
GLP-1 receptor: Moderate activation, contributing to appetite regulation and glucose control
-
Glucagon receptor: Balanced activation, supporting energy expenditure and lipid oxidation research
This triple targeting allows researchers to study receptor cross-talk and synergistic metabolic effects that single or dual agonists cannot replicate. The molecule includes two amino-isobutyric acid (Aib) substitutions and a C20 fatty diacid side chain via gamma-Glu-AEEA-Lys linkage, extending half-life and enabling sustained receptor engagement.
Molecular Profile:
-
Sequence: Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-α-Me-Leu-Leu-Asp-Lys-diacid-C20-gamma-Glu-(AEEA)-Lys-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
-
Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
-
Molecular Weight: 4731.33 g/mol
-
CAS: 2381089-83-2
-
Synonyms: Retatrutide acetate, LY3437943
Retatrutide Research Applications
Body Mass and Energy Expenditure Studies
The landmark Phase 2 trial published in the New England Journal of Medicine demonstrated that Retatrutide produced dose-dependent weight reduction in human subjects over 48 weeks. Researchers observed up to 24.2% mean weight loss at the highest dose, exceeding results from single and dual agonist comparators. Preclinical rodent models show similar effects through combined appetite suppression, increased energy expenditure, and enhanced lipid oxidation.
Glucose Regulation and Insulin Dynamics
Retatrutide improves glucose tolerance through multiple pathways. GLP-1 and GIP receptor activation enhances glucose-dependent insulin secretion. Glucagon receptor activation supports hepatic glucose handling during fasting states. Researchers study this compound to examine how triple receptor engagement affects insulin sensitivity, beta-cell function, and glycemic variability compared to selective agonists.
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
A randomized Phase 2a trial published in Nature Medicine examined Retatrutide in MASLD patients. After 48 weeks, 89% of subjects receiving the highest dose achieved resolution of steatosis with at least one stage of fibrosis improvement. Liver fat content decreased by approximately 85% from baseline. These findings position Retatrutide as a critical research tool for investigators studying liver metabolism, fibrosis regression, and non-invasive biomarker development.
Diabetic Kidney Disease Models
Comparative research in db/db mice examined Retatrutide against Liraglutide and Tirzepatide for renal protection endpoints. Retatrutide showed superior reductions in albuminuria, glomerular hypertrophy, and renal fibrosis markers. The triple agonist mechanism may offer renal protective effects beyond glycemic control, making it relevant for nephrology and cardiometabolic research programs.
Receptor Cross-Talk and Signaling Research
Retatrutide provides a unique tool for studying how concurrent GIP, GLP-1, and glucagon receptor activation influences downstream signaling. Researchers examine:
-
cAMP accumulation across receptor types
-
Beta-arrestin recruitment and receptor internalization kinetics
-
Cross-talk between incretin and glucagon pathways in hepatocytes and adipocytes
-
Differential tissue distribution and receptor occupancy
Retatrutide vs Tirzepatide: Research Comparison
Dual Agonist vs Triple Agonist
Researchers frequently ask which is better, tirzepatide or retatrutide. The answer depends on your study endpoints:
| Feature | Tirzepatide | Retatrutide |
|---|---|---|
| Receptor targets | GIP + GLP-1 | GIP + GLP-1 + Glucagon |
| Weight loss (human data) | Up to 22.5% | Up to 24.2% |
| Energy expenditure effect | Moderate | Enhanced via glucagon |
| Lipid oxidation | GLP-1 mediated | Glucagon + GLP-1 |
| Liver fat reduction | Significant | Superior (85% reduction) |
| Best for studying | Incretin synergy, appetite | Multi-pathway metabolic integration |
Research implication: Tirzepatide isolates incretin synergy. Retatrutide adds glucagon-mediated thermogenesis and hepatic lipid handling. For protocols examining complete metabolic remodeling rather than isolated pathways, Retatrutide provides more comprehensive data.
Is Retatrutide the Same as Ozempic?
Different Compounds, Different Mechanisms
No. Retatrutide is not the same as Ozempic. Ozempic (semaglutide) is a selective GLP-1 receptor agonist. Retatrutide activates three receptors simultaneously. The additional GIP and glucagon activity creates distinct metabolic effects:
-
Ozempic: Appetite suppression via GLP-1, delayed gastric emptying
-
Retatrutide: Appetite suppression + enhanced energy expenditure + hepatic lipid oxidation
Researchers studying GLP-1 in isolation use semaglutide. Researchers examining integrated metabolic regulation use Retatrutide to model how multiple hormonal pathways coordinate body mass and energy balance.
How to Reconstitute Retatrutide 20mg
Standard Laboratory Preparation
For researchers asking retatrutide how to mix, follow this protocol:
-
Sanitize the vial stopper with 70% isopropyl alcohol
-
Inject 2 mL bacteriostatic water slowly against the vial wall
-
Allow the lyophilized cake to dissolve without agitation (5-10 minutes)
-
Gently swirl if needed. Do not shake vigorously
-
Final concentration: 10 mg/mL
Storage after reconstitution:
-
Use within 14 days at 2-8°C
-
Do not freeze reconstituted solution
-
Protect from light at all stages
Handling Notes
Retatrutide contains a fatty diacid side chain that increases hydrophobicity. It dissolves more slowly than standard peptides. Patience during reconstitution prevents foaming and denaturation. For concentrations above 10 mg/mL, use 10% DMSO in sterile water.
Can I Buy Retatrutide? Regulatory Context
Research Procurement Status
Retatrutide is an investigational new drug not approved by the FDA for human use. It is not scheduled under the Controlled Substances Act. Can I buy retatrutide? Yes, for legitimate laboratory research. The FDA restricts marketing and medical claims, not bona fide research procurement.
You must purchase from a vendor that explicitly sells for research use only and requires agreement to those terms. Pure Peptide Factory operates under this framework exclusively.
Is Retatrutide FDA Approved?
No. Retatrutide has completed Phase 2 trials for obesity and MASLD. Phase 3 trials are ongoing. FDA approval for any indication would require successful completion of Phase 3 and regulatory review. This timeline does not affect research availability.
Is Retatrutide Available Yet?
For research purposes, yes. For clinical or human use, no. The scarcity you encounter when searching retatrutide how to get stems from limited synthesis capacity and import restrictions, not regulatory prohibition. Domestic suppliers with dedicated production lines maintain consistent availability.
Product Specifications
Available Configuration
Quality Verification
-
Purity: 98-99% minimum (HPLC verified)
-
Identity: Mass spectrometry confirmed
-
Endotoxin: <0.1 EU/mL
-
Sterility: Verified per USP <71>
-
Form: Lyophilized sodium salt
-
Storage: 2-8°C (≤-20°C long-term)
FAQ
Where can I buy Retatrutide?
Pure Peptide Factory stocks research-grade Retatrutide with domestic shipping. We are one of the few U.S.-based suppliers carrying this compound with consistent inventory.
How long does it take to see results from Retatrutide?
Published human data shows measurable weight reduction at 12 weeks, with progressive effects through 48 weeks. Rodent models show metabolic changes within 2-4 weeks. Timeline varies by species, dose, and endpoints.
What are the risks of taking Retatrutide?
As an investigational compound, comprehensive safety data is incomplete. Published Phase 2 data reports gastrointestinal effects (nausea, diarrhea), gallbladder events, and heart rate increases. Long-term safety requires Phase 3 completion.
How quickly does Retatrutide start working?
Pharmacokinetic data shows receptor engagement within hours of administration. Measurable metabolic effects emerge over days to weeks depending on the endpoint studied.
Can doctors prescribe Retatrutide?
No. Retatrutide is not FDA approved and cannot be legally prescribed for any indication. It is available only for laboratory research.
What should I avoid when taking Retatrutide?
This question applies to human use, which is not approved. For research handling, avoid repeated freeze-thaw cycles, exposure to light, and reconstitution in strong acids or bases.
Is Retatrutide available in the USA?
For research procurement, yes. Pure Peptide Factory ships to all 50 states. For clinical use, no. FDA approval is pending Phase 3 trial completion.
Retatrutide where to buy USA?
Right here. We ship from domestic inventory with 1-3 day delivery to U.S. research institutions.
Order Retatrutide for Research
Secure Checkout
-
Credit card, cryptocurrency, or wire transfer
-
Same-day dispatch before 2 PM EST
-
Cold-chain packaging with tracking
-
Discreet labeling
Institutional Accounts
Net-30 terms and purchase orders accepted for universities and pharmaceutical companies. Contact us for bulk pricing on 50+ vials.
Add to cart and secure your triple-agonist research supply before the next production batch sells out.
Related products
-
Survodutide 10 mg
$100.00
